Medical News

RSS

Deep brain stimulation reduces binge eating

Deep brain stimulation reduces binge eating in mice, suggesting that this surgery, which is approved for treatment of certain neurologic and psychiatric disorders, may also be an effective therapy for obesity. Presentation of the results will take place Sunday at The Endocrine Society's 94th Annual Meeting in Houston.

25 Jun 2012

Philips selects Acuo as partner for multi-site federated vendor neutral archive in UK

Acuo Technologies, the world leader in high-performance software and services for clinical content management and data migration, announced today it has been selected as the preferred supplier to work with technology partner and prime contractor Philips in the United Kingdom to implement a multi-site federated vendor neutral archive, featuring fully-distributed data management with centralized administration, to be shared across six NHS trusts in Surrey and Sussex.

25 Jun 2012

Standard aspirin dose may not protect diabetics against blood clots

Many patients with type 2 diabetes may be aspirin resistant. That means the standard aspirin dose may not protect them against blood clots that cause heart attacks and strokes among diabetics, a new clinical study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.

25 Jun 2012

Waiting for the word

Anticipation regarding the Supreme Court's health law decision -- expected this week and possibly even today -- has created a guessing-game situation in Washington. News outlets report on both the preparations being made and the reasons why this decision, and the challenge behind it, are historic and important.

25 Jun 2012

Comprehensive, automated infection outbreak detection system for the Olympics

The world's first comprehensive, automated outbreak detection system which will monitor over 3,000 infections and is ready to run during Olympics 2012, was developed by a researcher at The Open University.

25 Jun 2012

Degludec effectively lowers blood glucose with lower risk for hypoglycemia

An experimental insulin drug prevented low blood sugar among diabetic patients more often than a popular drug on the market, a new study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.

25 Jun 2012

Physically fit patients with LVH have a significantly lower risk of death

Being physically fit may improve survival rates among diabetes patients with a particular type of heart abnormality, a new study determines. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.

25 Jun 2012

Exposure to secondhand smoke may lead to obesity and Type 2 diabetes

Adults who are exposed to secondhand smoke have higher rates of obesity and Type 2 diabetes than do nonsmokers without environmental exposure to tobacco smoke, a new study shows. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.

25 Jun 2012

Mount Sinai offers transoral robotic surgery for sleep apnea treatment

The Center for Minimally Invasive and Robotic Surgery at The Mount Sinai Medical Center—a pioneer in robotic surgery—now offers the procedure to patients with sleep apnea, whose obstructive breathing prevents them from sleeping normally. Mount Sinai is one of only a few programs in the world to use transoral robotic surgery (TORS) to remove excess tissue or fix a collapsed airway that causes sleep apnea.

25 Jun 2012

Suicide leading cause of death among young people in India

Suicide has become the second-leading cause of death of young people in India, which has one of the highest suicide rates in the world, according to an Article published as part of the Lancet Series on suicide.

25 Jun 2012

Political cartoon: 'Exercise Guidelines?'

Kaiser Health News provides a fresh take on health policy developments with "Exercise Guidelines?" by Chris Wildt.

25 Jun 2012

NIH awards Sirnaomics SBIR grant for developing STP705 siRNA wound healing product

Sirnaomics, Inc. announced today that the company has been awarded another NIH SBIR grant for developing its small interfering RNA (siRNA) therapeutic product STP705 to improve skin wound healing with minimized scar formation.

25 Jun 2012

Neuralstem commences dosing in NSI-189 Phase Ib trial for major depressive disorder

Neuralstem, Inc. announced that the first patients were dosed in Phase Ib of its ongoing trial to test the safety of NSI-189 in the treatment of major depressive disorder (MDD).

25 Jun 2012

Suicides could be prevented by means restriction

In the third Series paper, Means restriction for suicide prevention, Professor Paul Yip of the Centre for Suicide Research and Prevention, University of Hong Kong, China, and colleagues review the evidence for means restriction in preventing suicides. Despite the fact that some suicide methods are difficult to restrict, the researchers highlight the fact that means restriction remains one of the most effective ways to reduce suicide rates.

25 Jun 2012

FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] as a treatment for multifocal motor neuropathy (MMN). This is the first immunoglobulin treatment approved for MMN patients in the United States, and it was approved for use with MMN patients in Europe in 2011.

From Baxter International Inc. 25 Jun 2012

High suicide rates in specific regions or ethnic groups may be masked by falls in national rates for young men

In the second Series paper, Suicide in young men, a group of researchers led by Dr Alexandra Pitman of UCL (University College London) Mental Health Sciences Unit, UK, examine another under-investigated area of suicide research. After reviewing research published over the last decade, they found strikingly few studies distinguishing the factors which identify those young men (aged 19 – 30) at greatest risk of suicide.

25 Jun 2012

First Edition: June 25, 2012

Today's headlines are focused on analysis and speculation surrounding the Supreme Court's health law ruling, which could come as early as today.

25 Jun 2012

FDA approves Actavis Mixed Amphetamine Salts ER Capsules

Actavis Group, an international generic pharmaceuticals company, today announced that it has received approval from the US Food & Drug Administration to market Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules CII, (hereafter referred to as Mixed Amphetamine Salts ER Capsules), in all available strengths: 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg.

25 Jun 2012

Self-harm and suicide in young people: the role of new media

In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford’s Centre for Suicide Research, and Professor Rory O’Connor of University of Stirling’s Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.

25 Jun 2012

Staff at Sheffield Teaching Hospitals shortlisted for more awards than any other trust in the country

Teams of staff at Sheffield Teaching Hospitals have been recognised for their hard work by gaining more shortlisted entries in two high profile national award schemes than any other trust in the country.

25 Jun 2012